Gallic Acid Has Anticancer Activity and Enhances the Anticancer Effects of Cisplatin in Non‑small Cell Lung Cancer A549 Cells via the JAK/STAT3 Signaling Pathway

Oncology Reports - Greece
doi 10.3892/or.2019.6976
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Vorinostat Enhances the Cisplatin-Mediated Anticancer Effects in Small Cell Lung Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Anticancer Effects of Isofraxidin Against A549 Human Lung Cancer Cells via the EGFR Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Bisphosphonamidate Clodronate Prodrug Exhibits Potent Anticancer Activity in Non-Small-Cell Lung Cancer Cells

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2011English

Long Noncoding RNA PART1 Promotes Progression of Non‐small Cell Lung Cancer Cells via JAK‐STAT Signaling Pathway

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Phloretin Exhibits an Anticancer Effect and Enhances the Anticancer Ability of Cisplatin on Non-Small Cell Lung Cancer Cell Lines by Regulating Expression of Apoptotic Pathways and Matrix Metalloproteinases

International Journal of Oncology
Cancer ResearchOncology
2015English

A Novel Imidazopyridine PI3K Inhibitor With Anticancer Activity in Non-Small Cell Lung Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2013English

Interleukin-17 Promotes Angiogenesis by Stimulating VEGF Production of Cancer Cells via the STAT3/GIV Signaling Pathway in Non-Small-Cell Lung Cancer

Scientific Reports
Multidisciplinary
2015English

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin

Frontiers in Pharmacology
Pharmacology
2020English

FAM98A Promotes Proliferation of Non-Small Cell Lung Cancer Cells via the P38-Atf2 Signaling Pathway

Cancer Management and Research
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy